serranJS Profile Banner
Juan C Serrano, MD, PhD Profile
Juan C Serrano, MD, PhD

@serranJS

Followers
154
Following
715
Media
13
Statuses
90

Transitional year intern @mhshospital, future radiology resident @UCSF. Penn MSTP alum🩺🧬, Gates-Cambridge Scholar, UF grad🐊. I want to believe👽.

Coral Springs, FL
Joined June 2010
Don't wanna be here? Send us removal request.
@serranJS
Juan C Serrano, MD, PhD
1 year
Proud to announce I’ll be going to Memorial Healthcare in South Florida for 1 year of general medicine, then University of California - San Francisco for 4 years of Diagnostic Radiology!!.Eternally grateful to my parents and family for their support since day 1. @RadsUcsf
Tweet media one
7
3
111
@serranJS
Juan C Serrano, MD, PhD
1 year
RT @RemiBuisson: Now online! APOBEC3A and APOBEC3B drive distinct mutational landscapes in tumors. We showed how A3A and A3B substrate pref….
0
37
0
@serranJS
Juan C Serrano, MD, PhD
2 years
Had a great time at my first #RSNA hearing about cutting-edge radiology research and meeting colleagues as a #FutureRadRes. Wonderful to see MCCormick Place from SkyEdge as well!.@RSNA @RSNATrainees
Tweet media one
1
0
2
@serranJS
Juan C Serrano, MD, PhD
2 years
Thought Spanish-speaking #MedTwitter would get a kick out of this exchange with my dad. #Match2024 #RadTwitter #FutureRadRes
Tweet media one
0
0
7
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @Jairo_I_Funez: Although the implosion of OceanGate’s Titan was heard from the very beginning and death was certain, resources were stil….
0
1K
0
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @twang0518: Excited to share our paper out today in @nchembio! DM-Seq is our non-destructive approach for detecting DNA methylation. We….
0
11
0
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @muhil_ravi: My name is Muhil, and I first came to the United States when I was 2 years old. Despite living here lawfully for two decade….
0
967
0
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @MBurt34: I made a map
Tweet media one
0
56
0
@serranJS
Juan C Serrano, MD, PhD
2 years
When the fellow starts ranting about med students not really learning and relying on those “sketchy cartoons”
Tweet media one
1
0
4
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @CDR3b: @RiderToast (with phd friends) ugh clinicians am I right .(with md friends) ugh researchers am I right .(with md phd friends) my….
0
15
0
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @lachristensen: 24 days ago I learned my daughter was dying in utero, and if untreated I risked preeclampsia and stroke. Termination is….
0
4K
0
@serranJS
Juan C Serrano, MD, PhD
2 years
RT @uffdaALLberries: 1/ Excited (and relieved) to share our new work with @arjunrajlab on identifying intrinsic factors marking rare somati….
0
30
0
@serranJS
Juan C Serrano, MD, PhD
3 years
I could not have picked a more supportive lab than the @KohliLab to pursue the PhD portion of my MD-PhD and develop my skills as a chemical biologist. Our DNA dumbbell story is yet to be over, so be on the lookout as we advance our modulators to the cellular realm!.
1
0
4
@serranJS
Juan C Serrano, MD, PhD
3 years
These efforts could not have been possible without the strong collaboration with the @DmochowskiUPenn lab and Dora von Trentini, as well as the amazing @Berrios_KN and @AleksiaBarka.
1
0
3
@serranJS
Juan C Serrano, MD, PhD
3 years
These DNA-based inhibitors provide a proof-of-concept for the importance of looking beyond the more obvious features of protein substrates for designing molecular probes. After all, nature has shown us time and time again that structure dictates function.
Tweet media one
1
1
5
@serranJS
Juan C Serrano, MD, PhD
3 years
Most importantly, we show our DNA dumbbells are specific inhibitors of A3A, as they have markedly reduced activity against closely related A3B, another oncogenic deaminase, and A3F, replicating each enzyme's mutational preference observed in nature.
Tweet media one
1
0
3
@serranJS
Juan C Serrano, MD, PhD
3 years
We found simply changing the shape of the DNA backbone yielded a near 35-fold improvement in activity to nanomolar-level potency, when compared to a nonstructured inhibitor. We then interrogated which inhibitor features conferred this potency and which were open to modification.
Tweet media one
Tweet media two
1
0
3
@serranJS
Juan C Serrano, MD, PhD
3 years
With this insight into A3A's targeted activity on the genome, we hypothesized that by placing an inhibitory nucleobase, 5-methylzebularine (mZ), in a DNA scaffold mimicking a hairpin, such as a DNA dumbbell, we could design a more potent and specific inhibitor.
Tweet media one
1
0
4